All lobbying filings

MCDERMOTT+

MCDERMOTT+ filed a Q1 report for PATIENTS FOR AFFORDABLE DRUGS NOW on April 1, 2026, reporting $30,000 in lobbying income.

Lobbying for PATIENTS FOR AFFORDABLE DRUGS NOW · non-partisan national patient organization fighting to lower drug prices

All filings by MCDERMOTT+ · Everything PATIENTS FOR AFFORDABLE DRUGS NOW has reported

Filing · LD-2 quarterly report Q1 report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 1, 2026

Income

$30,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Lobbyists on this filing 7

DEBRA CURTIS

Previously held: 1998-2013: Legislative Director, Chief of Staff, Rep. Pete Stark; jointly Professional Staff on Committee on Ways and Means, Health Subcommittee
RODNEY WHITLOCK

Previously held: 2011-2015: Health Policy Director, Sen. Chuck Grassley; 2005-2010: Health Policy Advisor, Senate Finance Committee; 2003-2005: Legislative Director, Rep. Charlie Norwood; 1997-2002: Legislative Assistant, Rep. Charlie Norwood
AMY KELBICK

Previously held: 2015-2017: Senior Policy Advisor, Rep. Jan Schakowsky; 2013-2015: Senior Legislative Assistant, Rep. Bill Foster; 2009-2013: Legislative Assistant, Staff Assistant, Rep. Maurice Hinchey
JULIA GRABO

Previously held: 2021: Paid Intern, Rep. Colin Allred
JOSH JORGENSEN New on this filing

Previously held: 2017-2020: Senior Legislative Correspondent; Legislative Aide, Sen. Mike Rounds
ERIN ELIZABETH FULLER New on this filing

Previously held: 2020: Paid Intern, Rep. Elissa Slotkin
MADALYN NEWS

Previously held: 2020: Paid Intern, Rep. Madeleine Dean

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Health Issues

Issues related to prescription drug competition and pricing.

Consumer Issues/Safety/Products

Issues related to prescription drug competition and pricing.

Medicare/Medicaid

Issues related to prescription drug competition, pricing and pharmacy benefit management reforms.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.